---
schema_version: "secwatch.filing_event.v1"
accession: "0001636422-24-000072"
form_type: "8-K"
ticker: "HCAT"
cik: "0001636422"
company_name: "Health Catalyst, Inc."
filed_at: "2024-05-09T23:59:59+00:00"
generated_at: "2026-06-02T06:08:39.595520+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Health Catalyst Q1 revenue $74.7M, Adj EBITDA $3.4M; beats guidance mid-point

## Summary
- Q1 total revenue $74.7M (up 1% YoY), net loss $20.6M (improved 38% from $33.2M loss).
- Adjusted EBITDA $3.4M above Q1 guidance range of $2M-$4M.
- Reiterates FY2024 revenue guidance $304M-$312M and Adj EBITDA $24M-$26M.
- Q2 2024 guidance: revenue $73.5M-$76.5M, Adj EBITDA $5M-$7M.
- New platform branded Health Catalyst Ignite; expansion with Saudi German Health announced.

## SEC filing metadata
- accession: 0001636422-24-000072
- form_type: 8-K
- ticker: HCAT
- cik: 0001636422
- company_name: Health Catalyst, Inc.
- filed_at: 2024-05-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636422/000163642224000072/0001636422-24-000072-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636422/000163642224000072/hcat-20240509.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001636422-24-000072
- JSON: https://secwatch.observer/filing/0001636422-24-000072.json
- Plain text: https://secwatch.observer/filing/0001636422-24-000072.txt

## Key facts
- Earnings Releases
  Health Catalyst, Inc. reported the quarter ended March 31, 2024 results: revenue $74.7 million.
  - Period: the quarter ended March 31, 2024
  - Revenue: $74.7 million
  - Result: reported results
  source text: today reported financial results for the quarter ended March 31, 2024. “For the first quarter of 2024, I am pleased by our strong financial results, including total revenue of $74.7 million and Adjusted EBITDA of $3.4 million, with these results beating the mid-point of our quarterly guidance on each metric. This financial performance demonstrates our ability to
  evidence_url: https://www.sec.gov/Archives/edgar/data/1636422/000163642224000072/0001636422-24-000072-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.